Accent Microcell extends its product reach to more than 45 countries, including the USA, Canada, and Germany. The company operates two manufacturing units, namely Pirana and Dahej, Gujarat, ensuring prompt, efficient, and tailored product deliveries to meet specific demographic requirements.
There was a growth in export revenue, witnessing a CAGR of 23.64%, rising from Rs. 84.70 crores in 2021 to Rs. 129.493 crores in 2023.
The company faces a risk associated with limited suppliers providing raw materials lacking long-term agreements or contracts. Accent Microcell is vulnerable to price and supply fluctuations for essential raw materials.
Export sales heavily rely on specific countries, including Brazil, the United Kingdom, the United States, Russia, the Republic of Korea, Turkey, Germany, Bangladesh, Egypt, the Netherlands, and Indonesia.
A significant portion of the company's revenues is linked to the pharmaceutical industry, making it susceptible to adverse impacts if key customers are lost.
Accent Microcell is yet to finalize orders for 100% of the equipment, plant, and machinery for the Proposed Unit at Navagam Kheda. Delays in procurement may affect the implementation schedule and increase operational commencement costs.
Domestic sales are concentrated in 5 states, namely Gujarat, Himachal Pradesh, Maharashtra, Uttarakhand, and Telangana. Any business loss in these states could negatively impact revenues and profitability.
As of June 30, 2023, the company has outstanding secured loans amounting to Rs. 18.82 crores. Defaulting on repayment could lead to the forfeiture of properties by lenders, significantly affecting business, financial condition, or results of operations.
Accent Microcell's dependency on third-party transportation providers for raw material supply and product delivery poses a potential operational risk.
The Dahej Unit's premises are not owned but are on a lease arrangement. Any termination or non-renewal of the lease/license or attachment by the property owner could adversely affect operations.